NCT02228720View on ClinicalTrials.gov

Clinical Evaluation of Propel Nova Sinus Implant in Peripheral Sinus Ostia

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

January 31, 2015

Conditions
Chronic Sinusitis
Interventions
DEVICE

Propel Nova Sinus Implant

Bioabsorbable, steroid-releasing sinus implant with 370 mcg of mometasone furoate released over 30 days

Trial Locations (2)

33176

South Florida ENT Associates, Miami

43016

Ohio Sinus Institute, Dublin

Sponsors

Lead Sponsor

Intersect ENT
All Listed Sponsors
lead

Intersect ENT

INDUSTRY